Enveric Biosciences, Inc. (ENVB)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
1.48
+0.07
(+4.96%)
After-Hours: 20:00
Enveric Biosciences Total Liabilities (Quarterly) : 0.8615M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8615M |
| March 31, 2026 | 0.4607M |
| December 31, 2025 | 0.9184M |
| September 30, 2025 | 0.9059M |
| June 30, 2025 | 1.364M |
| March 31, 2025 | 1.184M |
| December 31, 2024 | 1.490M |
| September 30, 2024 | 0.8392M |
| June 30, 2024 | 0.6453M |
| March 31, 2024 | 2.368M |
| December 31, 2023 | 2.344M |
| September 30, 2023 | 4.184M |
| June 30, 2023 | 4.926M |
| March 31, 2023 | 4.438M |
| December 31, 2022 | 3.996M |
| September 30, 2022 | 7.254M |
| June 30, 2022 | 5.968M |
| March 31, 2022 | 7.737M |
| December 31, 2021 | 4.413M |
| September 30, 2021 | 14.39M |
| June 30, 2021 | 4.876M |
| March 31, 2021 | 6.795M |
| December 31, 2020 | |
| September 30, 2020 | 14.82M |
| June 30, 2020 | 14.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.91M |
| December 31, 2019 | 14.38M |
| September 30, 2019 | 13.41M |
| June 30, 2019 | 18.62M |
| March 31, 2019 | 19.34M |
| December 31, 2018 | 18.88M |
| September 30, 2018 | 15.81M |
| June 30, 2018 | 27.24M |
| March 31, 2018 | 28.75M |
| December 31, 2017 | 32.75M |
| September 30, 2017 | 34.92M |
| June 30, 2017 | 33.67M |
| March 31, 2017 | 34.91M |
| December 31, 2016 | 27.84M |
| September 30, 2016 | 33.37M |
| June 30, 2016 | 12.73M |
| March 31, 2016 | 13.43M |
| December 31, 2015 | 13.58M |
| September 30, 2015 | 20.25M |
| June 30, 2015 | 9.318M |
| March 31, 2015 | 0.0103M |
| December 31, 2014 | 0.009M |
| September 30, 2014 | 0.0023M |
| June 30, 2014 | 0.002M |
| March 31, 2014 | 0.0048M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 17.33M |
| Impact BioMedical, Inc. | 2.733M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.944M |
| Shareholders Equity (Quarterly) | 8.082M |
| Current Ratio | 10.21 |